Shabet Rose Sharon

10% owner at RayzeBio, Inc. · on record since Sep 21, 2023
10% owner at LABRANCHE & CO INC · on record since Mar 20, 2024
10% owner at APi Group Corp · on record since Mar 7, 2024
10% owner at Glori Energy Inc. · on record since Jun 7, 2024
10% owner at TIC Solutions, Inc. · on record since Feb 14, 2025
10% owner at FIGS, Inc. · on record since Jun 7, 2021
10% owner at GENENTECH INC · on record since Sep 23, 2021
10% owner at Myovant Sciences Ltd. · on record since Jul 10, 2017
10% owner at AXON ENTERPRISE, INC. · on record since Jul 10, 2017
10% owner at Arbutus Biopharma Corp · on record since Jul 10, 2017
10% owner at Urovant Sciences Ltd. · on record since Sep 26, 2018
10% owner at BridgeBio Pharma, Inc. · on record since Jun 28, 2019
10% owner at Steel Excel Inc. · on record since Jun 26, 2019
Former 10% Owner at Urovant Sciences Ltd. · on record since Jul 12, 2019
Former 10% Owner at Arbutus Biopharma Corp · on record since Jul 12, 2019
Former 10% Owner at AXON ENTERPRISE, INC. · on record since Jul 12, 2019
Former 10% Owner at Myovant Sciences Ltd. · on record since Jul 12, 2019
10% owner at ADVANCED PHOTONIX INC · on record since Apr 28, 2020
10% owner at · on record since Apr 8, 2020
10% owner at · on record since Aug 28, 2020
10% owner at · on record since Dec 17, 2020
10% owner at · on record since Sep 21, 2021
10% owner at · on record since Aug 2, 2021
10% owner at · on record since Oct 1, 2021
10% owner at · on record since Jan 13, 2022
10% owner at · on record since Nov 25, 2022

Insider trading activity of Shabet Rose Sharon

Transactions on record: 21; since Jun 14, 2019

Open-market buys: 7; $118.8M

Open-market sells: 2; $9.4M

Companies traded: 5; last filing Sep 21, 2023

Figures computed from official regulatory filings — .

Companies where Shabet Rose Sharon has traded

10 tx · $25M · Sep 21, 2023
1 tx · $13.6M · May 11, 2023
2 tx · $9.4M · Sep 3, 2021
5 tx · $80M · Jun 28, 2019
3 tx · $177.3K · Jun 14, 2019

Track record of Shabet Rose Sharon

Statistical track record

Free account

Open-market buys: 7

Last buy: Sep 19, 2023

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Shabet Rose Sharon

Co-insiders of Shabet Rose Sharon

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-864,509	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	1,285,223	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	494,687	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-2,609,392	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	2,609,392	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-1,285,223	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	864,509	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-432,254	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Buy	458,333	18.00 USD	$8.2M	conv 47Cluster	SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Buy	930,556	18.00 USD	$16.8M	conv 44Cluster	SEC
4D Molecular Therapeutics, Inc.Listing on record	May 11, 2023	Buy	850,000	16.00 USD	$13.6M	conv 43First in 12mo	SEC
FIGS, Inc.Listing on record	Sep 3, 2021	Sell	-157,587	47.28 USD	$7.5M		SEC
FIGS, Inc.Listing on record	Sep 3, 2021	Sell	-42,413	44.92 USD	$1.9M		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	Other	10,178,954	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	Buy	4,705,900	17.00 USD	$80M	conv 47Unusual size	SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	OtherD (derivative)	-51,781,276	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	Other	11,736,137	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	OtherD (derivative)	-50,446,451	—	n/a (No price was disclosed in the filing)		SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,144	7.91 USD	$56.5K	conv 30Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,367	7.95 USD	$58.6K	conv 30Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,500	8.30 USD	$62.3K	conv 38ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-864,509	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	1,285,223	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	494,687	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-2,609,392	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	2,609,392	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-1,285,223	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Other	864,509	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	OtherD (derivative)	-432,254	—	n/a (No price was disclosed in the filing)		SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Buy	458,333	18.00 USD	$8.2M	conv 47Cluster	SEC
RayzeBio, Inc.Listing unverified	Sep 21, 2023	Buy	930,556	18.00 USD	$16.8M	conv 44Cluster	SEC
4D Molecular Therapeutics, Inc.Listing on record	May 11, 2023	Buy	850,000	16.00 USD	$13.6M	conv 43First in 12mo	SEC
FIGS, Inc.Listing on record	Sep 3, 2021	Sell	-157,587	47.28 USD	$7.5M		SEC
FIGS, Inc.Listing on record	Sep 3, 2021	Sell	-42,413	44.92 USD	$1.9M		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	Other	10,178,954	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	Buy	4,705,900	17.00 USD	$80M	conv 47Unusual size	SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	OtherD (derivative)	-51,781,276	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	Other	11,736,137	—	n/a (No price was disclosed in the filing)		SEC
BridgeBio Pharma, Inc.Listing on record	Jun 28, 2019	OtherD (derivative)	-50,446,451	—	n/a (No price was disclosed in the filing)		SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,144	7.91 USD	$56.5K	conv 30Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,367	7.95 USD	$58.6K	conv 30Cluster	SEC
Urovant Sciences Ltd.Listing unverified	Jun 14, 2019	Buy	7,500	8.30 USD	$62.3K	conv 38ClusterFirst in 12mo	SEC